As of the most recent data, CCCC shows a ROE of -41.02%. That is below the Healthcare sector average of 20.86%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 20.86%. C4 Therapeutics is at -41.02%, which is lower that average. That is roughly 296.7% below the sector mean. Use the comparison chart on this page to see how CCCC stacks up against individual peers as well.

Check the historical chart to see whether CCCC's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare C4 Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has C4 Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -41.02%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 20.86%, while CCCC is at -41.02%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.